Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial - Cheng, A L; Kang, Y K; Chen, Z (Lancet Oncol, 2009)
et al.